Skip to content

Public FDA record

Z-0355-2024: Infusomat Administration Sets as listed below: 362031 Infusomat Space Pump Set with Caresite Injection

Recall record Z-0355-2024 for B. Braun Medical, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0355-2024
Company in FDA record
B. Braun Medical, Inc.
FDA classification date
Dec 1, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

In affected products, the tubing outer diameter may vary in size or the length of tubing may be too short. Both issues may lead to false air-in-line alarms, which will stop the infusion and interrupt therapy. Interruptions or delays in medication administration may result in serious injury to patients which may be life-threatening (e.g. interruption of a vasopressor to a hemodynamically unstable patient) or may lead to death.

Source facts

Action
On November 1, 2023, the firm notified customers via URGENT MEDICAL DEVICE CORRECTION letters. Customers were informed that administration sets with lot number 0061902124 and higher were manufactured with revised specifications which should reduce the potential for false air-in-line alarms. After November 30, 2023, all lots distributed by BBMI will have been manufactured with these revised specifications. The firm provided interim measures for users to apply for affected product. For example, users should not use tubing with noticeably smaller outer diameter or which needs to be stretched to fit within the pump. If possible, unaffected lots of product should be diverted to areas that infuse high risk medications or other infusions with acute clinical effects due to initial limited supply of the new administration sets. Affected lots should be diverted to care areas that do not infuse high risk medications or other infusions with acute clinical effects. When infusing high risk medications or infusions with acute clinical effects, customers were advised to have a second pump with an administration set available for exchange in the event of a false alarm. If a second pump is not available, have a second administration set available for exchange in the event of a a false alarm. Additional patient monitoring is required. Adverse reactions or quality problems experienced with this product, or questions about this correction may be reported to BBMI s Postmarket Surveillance Department by calling 1-833-425-1464.
Initiated
2023-11-01
Root cause
Process control
Distribution
Distribution US nationwide, Canada and Germany.
Recall number
Z-0355-2024
Recall status
Open, Classified
CDRH record ID
203733
FDA classified
2023-12-01
Recall event number
93232

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗